Global Market "Rheumatoid Arthritis Industry" :Forcast 2025, Analysis, Research Report 2016

Description-

Executive Summary

Rheumatoid arthritis (RA) is a chronic inflammatory disorder that principally attacks synovial joints. It is one of the most common autoimmune diseases affecting people of all ages and races. RA affects the lining of joints, causing a painful swelling that can eventually result in bone erosion and joint deformity. It also leads to stiffness, and redness in the joints. The main factor causing rheumatoid arthritis remains unknown. However, according to studies around the world some of the genetic and environmental factors are found to be more probable causers.

Treatment of Rheumatoid Arthritis involves frequent drugs administration as RA is a progressive and incurable disease. Drugs used for treatment of RA are classified as first line agents- consisting of non steroidal anti-inflammatory drugs (NSAIDs) and steroids such as glucocorticoids and second line agents- consisting of disease modifying anti-rheumatic drugs such as chloroquine, gold salts, penicillamine, cyclosporine, and several biological agents like TNF-

To Browse a Report Detail with TOC @ http://www.researchmoz.us/global-rheumatoid-arthritis-market-trends-and-opportunities-2013-2018-report.html

Scope of the report

The report titled Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018) provides an in-depth analysis of global rheumatoid arthritis market with special focus on biologics drugs. It also accesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2013-18). Further, key drug manufacturers of the global rheumatoid arthritis market like Abbvie Inc. (Humira), Amgen Inc. (Enbrel), Johnson & Johnson (Remicade), Roche Holdings AG (Actemra) are profiled in the report.

Company Coverage
Abbvie Inc.
Amgen Inc.
Johnson & Johnson
Roche Holdings AG

To Free Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=186839

Table of Content

1. Executive Summary

2. Rheumatoid Arthritis: An Introduction
2.1 Rheumatoid Arthritis: Causes
2.2 Rheumatoid Arthritis: Symptoms & Diagnosis
2.2.1 Rheumatoid Arthritis: Symptoms
2.2.2 Rheumatoid Arthritis: Diagnosis

3. Rheumatoid Arthritis Treatment
3.1 Clinical Evolution of Rheumatoid Arthritis Treatment
3.2 Rheumatoid Arthritis: Drugs Treatment
3.2.1 First line agents
3.2.2 Second line agents

4. Global Rheumatoid Arthritis Market Analysis
4.1 Global Rheumatoid Arthritis Treatment Market: Size & Growth (Actual & Forecast)
4.2 Global Rheumatoid Arthritis Treatment Market Analysis
4.2.1 Global Biologics Drugs Market Size (Actual & Forecast)
4.2.2 Global Rheumatoid Arthritis Biologics Drugs Market Share (Actual & Forecast)
4.2.3 Global TNF-α target Antibody Market Size (Actual & Forecast)

5. Global Rheumatoid Arthritis Drug Market Analysis
5.1 Global TNF-α target Drugs Market
5.1.1 Global TNF-α target Market Size by Drugs (Actual & Forecast)
5.1.2 TNF-α target Market Share by Drugs (Actual & Forecast)
5.2 Rheumatoid Arthritis Drugs Market: Regional Analysis
5.2.1 Rheumatoid Arthritis Drugs Market Size in the U.S. (2012)
5.2.2 TNFα Blockers Drugs Market Size in the U.S. (2012)
5.2.3 Rheumatoid Arthritis Drugs Market Size in Korea

6. Global Rheumatoid Arthritis Market: Growth Drivers & Challenges
6.1 Growth Drivers
6.1.1 Increase in Incidence of Patients with Rheumatoid Arthritis
6.1.2 Global Aging Population
6.1.3 Global Healthcare Expenditure
6.2 Challenges
6.2.1 Pricing pressure
6.2.2 Patent Expiries
6.2.3 High Cost of Treatment
6.2.4 High R&D Costs

To Enquire Regarding This Report @ http://www.researchmoz.us/enquiry.php?type=E&repid=186839

For More Information Kindly Contact:

ResearchMoz

Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us